Patients presenting with thrombosis and a normal platelet count post-vaccination might be in an early stage of TTS. These patients should be continuously assessed for tbe development of thrombocytopenia. The use of non-heparin anticoagulant may be indicated 4 to 30 days after receiving either the Vaxzevria or Janssen COVID-19 vaccine [48,72]..